2. Tingbo Liang, Shiguo Xu, Jun Yu, Kezhen Shen, Donglin Li, and Shusen Zheng. Activation Pattern of Mitogen-Activated Protein Kinases in Early Phase of Different Size Liver Isografts in Rats. Liver Transplantation, 2005; 11(12): 1527-1532. (Corresponding Author)
3.W Wei-lin, J Jing, Z Shu-sen, W Li-hua, L Ting-bo, Y Song-feng, and Y Sheng, Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients Liver Transpl 2006, 12(5): 775-80. (Corresponding Author)
4.Sheng Yan, Zhenhua Tu, Weifeng Lu, Qiyi Zhang, Jiangjuan He, Zhiwei Li, Yi Shao, Weilin Wang, Min Zhang, and Shusen Zheng Clinical Utility of an Automated Pupillometer for Assessing and Monitoring Recipients of Liver Transplantation Liver Transpl 15:1718-1727, 2009 (Corresponding Author)
5. Yu S, Wu L, Jin J, Yan S, Jiang G, Xie H, Zheng S. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation. 2006;81(1):46-51. (Corresponding Author)
6. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008 Jun 27;85(12):1726-32.
7.Liang TB, Li DL, Liang L, Li JJ, Bai XL, Yu W, Wang WL, Shen Y, Zhang M, Zheng SS.Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells.Transplantation. 2008 Mar 27;85(6):863-9 (Corresponding Author)
8.Xu X, Ling Q, Zhang M, Gao F, He Z, You J, Zheng S. Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation. 2009 May 27;87(10):1514-9. (Corresponding Author)
9.S Yin, J Li, C Hu, X Chen, M Yao, M Yan, G Jiang, C Ge, H Xie, D Wan, S Yang, S Zheng, and J Gu. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity., Int J Cancer 2007, 120(7): 1444-50. (Corresponding Author)
10.Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.Predictive Value of Expression and Promoter Hypermethylation of XAF1 in Hepatitis B Virus-Associated Hepatocellular Carcinoma Treated with Transplantation. Ann Surg Oncol. 2008 Dec;15(12):3494-502. (Corresponding Author)
省部级以上获奖情况（第一完成人)：
1.胰十二指肠及肾一期移植 1994年 浙江省科技进步一等奖
2.胰十二指肠及肾一期移植 www.med126.com1996年 国家科技进步二等奖
3.肝肾联合移植的临床研究 2000年 浙江省科技进步一等奖
4.郑树森（个人) 2003年 浙江省科技技术重大贡献奖
5.原位肝移植治疗终末期肝病的应用与推广研究2005年 浙江省科技进步一等奖
6.供体过继免疫在肝脏移植中应用研究 2005年 中华医学科技三等奖
7.活体肝移植创新技术研究及临床应用2007年 浙江省科技进步一等奖
8肝移植技术创新体系的建立与推广应用 2008年 国家科技进步二等奖
9.肝移植围手术期肾功能评估及其预警价值研究 2009年 浙江省科技进步一等奖
上一页 [1] [2] [3] [4] 下一页
